Table 2 Characteristics of included lung cancer cases, 2002–2011
From: Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey
Variable | Results (n = 15,437) | |
|---|---|---|
Regiona, n (%) | ||
East | 7799 | (50.52) |
Central | 3653 | (23.66) |
West | 3985 | (25.81) |
Hospital type, n (%) | ||
General | 4658 | (30.17) |
Specialized | 10,779 | (69.83) |
Hospital level, n (%) | ||
3 A | 14,381 | (93.16) |
3 B or less | 1056 | (6.84) |
Gender | ||
Male | 10,786 | (69.87) |
Female | 4651 | (30.13) |
Age at diagnosis, years, mean ± SD | 59.53 ± 11.19 | |
Age at diagnosis, years | ||
< 45 | 1537 | (9.96) |
45–54 | 3373 | (21.85) |
55–64 | 5116 | (33.14) |
≥ 65 | 5411 | (35.05) |
Pathological typeb | ||
Squamous cell carcinoma | 5380 | (38.61) |
Adenocarcinoma | 4943 | (35.47) |
Others | 3611 | (25.91) |
Clinical stageb | ||
I | 2922 | (18.93) |
II | 2344 | (15.18) |
III | 4507 | (29.2) |
IV | 5005 | (32.42) |
Not reported | 659 | (4.27) |
The proportion of morphological verification, % | 12,291 | (79.64) |
Number of clinical visits per case, Median (P5-P95) | 1 (1–8) | |
Number of clinical visits per case | ||
1 | 8975 | (58.14) |
2 | 2182 | (14.13) |
3 | 1461 | (9.46) |
4 + | 2819 | (18.26) |
Number of length of stay per case, Median (P25-P75) | 26 (14–55) | |
Type of therapy | ||
Surgery | 2873 | (19) |
Radiotherapy | 1159 | (7.67) |
Surgery & Radiotherapy | 95 | (0.63) |
Chemotherapy | 4289 | (28.37) |
Surgery & Chemotherapy | 2627 | (17.37) |
Radiotherapy & Chemotherapy | 1486 | (9.83) |
Palliative care | 1923 | (12.72) |
Others | 668 | (4.42) |
% of cases with any comorbidities | 5098 | (33.02) |
% of cases with any complications | 1431 | (9.27) |